Key research from the 2013 Breast Cancer Symposium highlights new insights
(American Society of Clinical Oncology) New studies exploring breast cancer risk perceptions and use of radiotherapy and MRI for women with ductal carcinoma in situ (DCIS, a preinvasive form of breast cancer) were highlighted today in a virtual presscast in advance of the 2013 Breast Cancer Symposium. The Symposium will take place September 7-9, 2013, at the San Francisco Marriott Marquis in San Francisco. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 4, 2013 Category: Global & Universal Source Type: news
Terminology used to describe preinvasive breast cancer may affect patients' treatment preferences
When ductal carcinoma in situ (DCIS, a preinvasive malignancy of the breast) is described as a high-risk condition rather than cancer, more women report that they would opt for nonsurgical treatments, according to a research letter by Zehra B. Omer, B.A., of Massachusetts General Hospital - Institute for Technology Assessment, Boston, and colleagues. A total of 394 healthy women without a history of breast cancer participated in the study and were presented with three scenarios that described a diagnosis of DCIS as noninvasive breast cancer, breast lesion, or abnormal cells... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 29, 2013 Category: Consumer Health News Tags: Breast Cancer Source Type: news
Terminology Affects Breast Cancer Patients’ Treatment Preferences
(Ivanhoe Newswire) –New research shows that when ductal carcinoma in situ (DCIS, a preinvasive malignancy of the breast) is described as a high-risk condition instead simply cancer, more women report that they would opt for nonsurgical treatments. (Source: Medical Headlines From Ivanhoe.com)
Source: Medical Headlines From Ivanhoe.com - August 28, 2013 Category: Consumer Health News Source Type: news
The 'C' Word Affects DCIS Treatment Choice (CME/CE)
(MedPage Today) -- Women who heard the word "cancer" in describing ductal carcinoma in situ (DCIS) thought more aggressive treatment was better, a study showed. (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 27, 2013 Category: Hematology Source Type: news
Doctors, Choose Your Words Wisely (FREE)
By Amy Orciari Herman
When providers avoid the word "cancer" in describing ductal carcinoma in situ (DCIS), women are more likely to … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 27, 2013 Category: Primary Care Source Type: news
DCIS terms affect patient treatment preferences
When ductal carcinoma in situ (DCIS) is described as a high-risk condition (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 26, 2013 Category: Radiology Source Type: news
DCIS Is Not Like a RoseDCIS Is Not Like a Rose
A new study looks at the effect of terminology used to describe ductal carcinoma in situ on women and the treatment they choose. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 26, 2013 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Terminology used to describe preinvasive breast cancer may affect patients' treatment preferences
(The JAMA Network Journals) When ductal carcinoma in situ (DCIS, a preinvasive malignancy of the breast) is described as a high-risk condition rather than cancer, more women report that they would opt for nonsurgical treatments, according to a research letter by Zehra B. Omer, B.A., of Massachusetts General Hospital -- Institute for Technology Assessment, Boston, and colleagues. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 26, 2013 Category: Cancer & Oncology Source Type: news
Anglia Ruskin experts want introduction of new treatment model for ductal carcinoma in situ (DCIS) patients
Breast cancer specialists at Anglia Ruskin University are proposing the introduction of a new model to provide safer treatment for patients with ductal carcinoma in situ (DCIS), the most common form of non-invasive breast cancer. Writing in the latest edition of The Lancet Oncology journal, Professor John Benson and Professor Gordon Wishart state that therapies such as radiotherapy and tamoxifen, which can impair quality of life and increase health-care costs, are not necessary for all patients... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 20, 2013 Category: Consumer Health News Tags: Breast Cancer Source Type: news
Ductal Carcinoma In Situ of the Breast:
‘Making the Punishment Fit the Crime’
To make the punishment fit the crime, you would want the decision of whether or not to use adjuvants to be informed by the degree of risk that the DCIS would recur. What factors can predict for an increased risk of recurrence, or more importantly, the risk of an invasive breast cancer occurring? (Source: Cancer Network)
Source: Cancer Network - August 15, 2013 Category: Cancer & Oncology Source Type: news
Ductal Carcinoma In Situ - DCIS
A description and definition of ductal carcinoma in situ, with signs and symptoms, diagnostic tests, staging, and treatment. Learn more about ductal carcinoma in situ (DCIS) here. (Source: About.com Breast Cancer)
Source: About.com Breast Cancer - August 2, 2013 Category: Cancer & Oncology Authors: breastcancer.guide at about.com Tags: health Source Type: news
Some women with abnormal breast lesions may avoid surgery
Surgery is not always necessary for women with a type of breast tissue abnormality associated with a higher risk of cancer, according to a new study published online in the journal Radiology. Researchers said that periodic imaging and clinical exam are effective in these patients when radiology and pathology findings are benign and concordant, or in agreement. Atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) are abnormal breast lesions that occasionally appear as incidental findings in breast biopsies... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 1, 2013 Category: Consumer Health News Tags: Breast Cancer Source Type: news
Squamous Cell Carcinoma In-Situ
Eccentric and irregular pigmentation prompted a biopsy in this elderly woman with a history of basal cell carcinoma and melanoma. The surprising diagnosis was a heavily pigmented squamous cell carcinoma in-situ. (Source: Consultant Live)
Source: Consultant Live - July 29, 2013 Category: Primary Care Source Type: news
Stage 0 Colon Cancer - What is Stage 0 Colon...
Stage 0 colon cancer is the earliest stage possible and is also called carcinoma in situ. "Carcinoma" refers to cancer that starts in epithelial tissue and "in situ" means original position or place. Colon cancer is considered stage 0 when it hasn't moved from where it started; it's still restricted to the innermost lining of the colon. (Source: About.com Colon Cancer)
Source: About.com Colon Cancer - June 28, 2013 Category: Cancer & Oncology Authors: coloncancer.guide at about.com Tags: health Source Type: news
Definition of Carcinoma In Situ
An early stage of a cancer may be described as carcinoma in situ. What is the definition of carcinoma in situ? (Source: About.com Lung Cancer)
Source: About.com Lung Cancer - June 19, 2013 Category: Cancer & Oncology Authors: lungcancer.guide at about.com Tags: health Source Type: news
